Analyst consensus rating
Veracyte Analyst Rating: none
Direct answer
Veracyte's consensus rating is none.
11 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $57.82.
Forecast evidence checked September 7, 2026.
Get free Veracyte email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $42.53
- Average price target
- $57.82
- High price target
- $70.00
- Low price target
- $44.00
- Low target gap
- +3.5%
- Target upside
- +35.9%
- High target gap
- +64.6%
- Target range width
- 61.1%
- Consensus rating
- none
- Analysts
- 11
- Evidence date
- September 7, 2026
- Valid through
- September 14, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Veracyte?
Veracyte has a verified none consensus. The same dataset has an average price target of $57.82.
How far are Veracyte's low and high targets from the recorded price?
The low target implies +3.5%, while the high target implies +64.6%.
How many analysts are included in Veracyte's consensus?
The verified consensus includes 11 analysts.
How is Veracyte's target upside or downside calculated?
The average target of $57.82 is divided by the recorded price of $42.53, then one is subtracted to produce +35.9%. This does not guarantee a future return.
When was Veracyte's analyst forecast verified?
The data was verified on 2026-09-07. The dataset is valid through 2026-09-14.